Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | -76.12%64K | -76.12%64K | -98.14%268K | -98.14%268K | 8,325.73%14.41M | 8,325.73%14.41M | -21.20%171K | -21.20%171K | -61.71%217K | -61.71%217K |
| -Cash and cash equivalents | -76.12%64K | -76.12%64K | -98.14%268K | -98.14%268K | 8,325.73%14.41M | 8,325.73%14.41M | -21.20%171K | -21.20%171K | -61.71%217K | -61.71%217K |
| Securities and investments | ---- | ---- | --24.45M | --24.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Short term investments | ---- | ---- | --24.45M | --24.45M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net loan | 2,596.74%38.11M | 2,596.74%38.11M | -86.41%1.41M | -86.41%1.41M | -57.55%10.4M | -57.55%10.4M | 20.10%24.5M | 20.10%24.5M | --20.4M | --20.4M |
| -Gross loan | 2,596.74%38.11M | 2,596.74%38.11M | -86.41%1.41M | -86.41%1.41M | -57.55%10.4M | -57.55%10.4M | 20.10%24.5M | 20.10%24.5M | --20.4M | --20.4M |
| Receivables | 6,557.14%466K | 6,557.14%466K | -22.22%7K | -22.22%7K | 50.00%9K | 50.00%9K | -76.92%6K | -76.92%6K | -93.73%26K | -93.73%26K |
| -Other receivables | 6,557.14%466K | 6,557.14%466K | -22.22%7K | -22.22%7K | 50.00%9K | 50.00%9K | -76.92%6K | -76.92%6K | -93.73%26K | -93.73%26K |
| Total assets | 47.83%38.64M | 47.83%38.64M | 5.31%26.14M | 5.31%26.14M | 0.57%24.82M | 0.57%24.82M | 19.54%24.68M | 19.54%24.68M | 4.02%20.64M | 4.02%20.64M |
| Liabilities | ||||||||||
| Payables | 371.81%1.59M | 371.81%1.59M | 16.21%337K | 16.21%337K | 6.62%290K | 6.62%290K | 98.54%272K | 98.54%272K | -63.31%137K | -63.31%137K |
| -Accounts payable | 88.41%130K | 88.41%130K | -52.41%69K | -52.41%69K | 504.17%145K | 504.17%145K | 4.35%24K | 4.35%24K | -58.82%23K | -58.82%23K |
| -Dividends payable | ---- | ---- | ---- | ---- | ---- | ---- | 19.23%124K | 19.23%124K | -42.79%104K | -42.79%104K |
| -Other payable | 444.78%1.46M | 444.78%1.46M | 84.83%268K | 84.83%268K | 16.94%145K | 16.94%145K | 1,140.00%124K | 1,140.00%124K | -92.63%10K | -92.63%10K |
| Total liabilities | 371.81%1.59M | 371.81%1.59M | 16.21%337K | 16.21%337K | 6.62%290K | 6.62%290K | 98.54%272K | 98.54%272K | -63.31%137K | -63.31%137K |
| Shareholders'equity | ||||||||||
| Share capital | 33.40%49.64M | 33.40%49.64M | -0.01%37.21M | -0.01%37.21M | 0.00%37.22M | 0.00%37.22M | 12.11%37.22M | 12.11%37.22M | 70.49%33.2M | 70.49%33.2M |
| -common stock | 33.40%49.64M | 33.40%49.64M | -0.01%37.21M | -0.01%37.21M | 0.00%37.22M | 0.00%37.22M | 12.11%37.22M | 12.11%37.22M | 70.49%33.2M | 70.49%33.2M |
| Retained earnings | 0.73%-12.6M | 0.73%-12.6M | -0.02%-12.69M | -0.02%-12.69M | -0.02%-12.69M | -0.02%-12.69M | 0.03%-12.69M | 0.03%-12.69M | ---12.69M | ---12.69M |
| Total stockholders'equity | 51.07%37.05M | 51.07%37.05M | -0.02%24.52M | -0.02%24.52M | -0.01%24.53M | -0.01%24.53M | 19.62%24.53M | 19.62%24.53M | 5.31%20.51M | 5.31%20.51M |
| Noncontrolling interests | ---- | ---- | --1.28M | --1.28M | ---- | ---- | ---- | ---- | ---- | ---- |
| Total equity | 43.60%37.05M | 43.60%37.05M | 5.18%25.8M | 5.18%25.8M | -0.01%24.53M | -0.01%24.53M | 19.62%24.53M | 19.62%24.53M | 5.31%20.51M | 5.31%20.51M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |